Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab
- PMID: 14694058
- DOI: 10.1212/01.wnl.0000098996.02934.86
Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab
Abstract
Two patients with chronic motor neuropathy, high antiganglioside antibody (AGA) titers, and a declining response to IV immunoglobulins were treated with rituximab at a standard dose. The drug was well tolerated and effectively eliminated peripheral B cells (CD20+), but AGA titers continued significantly high. No clinical improvement was detected during the 1-year follow-up.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous